Generation and Characterization of Typhoid Toxin-Neutralizing Human Monoclonal Antibodies.


Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
18 09 2020
Historique:
received: 14 05 2020
accepted: 06 07 2020
pubmed: 15 7 2020
medline: 7 4 2021
entrez: 15 7 2020
Statut: epublish

Résumé

Typhoid toxin is a virulence factor of

Identifiants

pubmed: 32661121
pii: IAI.00292-20
doi: 10.1128/IAI.00292-20
pmc: PMC7504945
pii:
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
Antibodies, Neutralizing 0
Bacterial Proteins 0
Bacterial Toxins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI079022
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114618
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI079022
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Lancet Glob Health. 2014 Apr;2(4):e195-6
pubmed: 25103052
Cell. 2014 Dec 4;159(6):1290-9
pubmed: 25480294
Lancet Glob Health. 2018 Oct;6(10):e1062-e1063
pubmed: 30223978
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4614-9
pubmed: 15070766
J Biol Chem. 2014 Jun 27;289(26):18008-21
pubmed: 24821719
Lancet Glob Health. 2017 Oct;5(10):e969
pubmed: 28911760
Nat Biotechnol. 2014 Apr;32(4):356-63
pubmed: 24633243
Annu Rev Pathol. 2011;6:365-93
pubmed: 21073341
J Mol Biol. 2017 Apr 7;429(7):1030-1044
pubmed: 28232034
BMC Infect Dis. 2014 Feb 10;14:73
pubmed: 24512443
Arch Dis Child. 1996 Sep;75(3):214-7
pubmed: 8976660
Clin Infect Dis. 2015 Aug 1;61(3):393-402
pubmed: 25870324
PLoS Pathog. 2019 Apr 5;15(4):e1007704
pubmed: 30951565
mBio. 2014 Apr 08;5(2):e00995
pubmed: 24713323
J Biol Chem. 2018 Jan 19;293(3):941-952
pubmed: 29180448
Clin Infect Dis. 2018 Aug 1;67(4):628-638
pubmed: 29522159
Nat Microbiol. 2017 Dec;2(12):1592-1599
pubmed: 28993610
N Engl J Med. 2002 Nov 28;347(22):1770-82
pubmed: 12456854
Cell Host Microbe. 2008 Jan 17;3(1):30-8
pubmed: 18191792
Z Naturforsch C J Biosci. 2000 May-Jun;55(5-6):489-93
pubmed: 10928566
Cell Microbiol. 2018 Dec;20(12):e12948
pubmed: 30152075
Rev Infect Dis. 1991 Jan-Feb;13(1):85-90
pubmed: 2017639
Antimicrob Agents Chemother. 2007 Dec;51(12):4315-23
pubmed: 17908946
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11736-41
pubmed: 12192086
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):6338-44
pubmed: 27222578
Ann Acad Med Singap. 2016 Jul;45(7):297-302
pubmed: 27523510
Expert Rev Vaccines. 2017 Oct;16(10):1029-1043
pubmed: 28856924
Nat Med. 2019 Jul;25(7):1082-1088
pubmed: 31270506
Annu Rev Microbiol. 2014;68:317-36
pubmed: 25208300
Nat Microbiol. 2018 Feb;3(2):155-163
pubmed: 29203881
Toxins (Basel). 2019 Jul 16;11(7):
pubmed: 31315299
Expert Rev Vaccines. 2013 Sep;12(9):1021-31
pubmed: 24053396
Lancet Glob Health. 2014 Oct;2(10):e570-80
pubmed: 25304633
Cell Host Microbe. 2018 Jan 10;23(1):65-76.e6
pubmed: 29324231
Nat Commun. 2017 Nov 16;8(1):1568
pubmed: 29146922
Clin Infect Dis. 2019 Oct 30;69(Suppl 6):S435-S448
pubmed: 31665781
J Glob Health. 2012 Jun;2(1):010401
pubmed: 23198130
Int J Med Sci. 2014 May 14;11(7):732-41
pubmed: 24904229
Bull World Health Organ. 2008 Apr;86(4):260-8
pubmed: 18438514
J Biol Chem. 2014 Oct 24;289(43):29874-80
pubmed: 25210036
Nature. 2013 Jul 18;499(7458):350-4
pubmed: 23842500
Nat Commun. 2019 Aug 15;10(1):3684
pubmed: 31417089
Cochrane Database Syst Rev. 2018 May 31;5:CD001261
pubmed: 29851031

Auteurs

Xuyao Jiao (X)

Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, Connecticut, USA.

Sarah Smith (S)

Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom.

Gabrielle Stack (G)

Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, Connecticut, USA.

Qi Liang (Q)

Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom.

Allan Bradley (A)

Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom.

Paul Kellam (P)

Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom.

Jorge E Galán (JE)

Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, Connecticut, USA jorge.galan@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH